ESC 365 - Main limiting factors of foundational therapy introduction in patients with heart failure with reduced ejection fraction

HFA Premium Access

Main limiting factors of foundational therapy introduction in patients with heart failure with reduced ejection fraction

Session: Heart Failure ePosters - focus on Chronic Heart Failure 1

Topic: Pharmacotherapy

Speaker: Doctor J. Brito (Lisbon, PT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Joana Brito

Santa Maria University Hospital CHLN Lisbon Academic Medical Centre, Lisbon (Portugal)

0 follower

38 more presentations in this session

Empagliflozin improves cardiovascular and renal outcomes in patients with preserved ejection fraction irrespective of age: insights from the EMPEROR-Preserved trial

Speaker: Professor M. Boehm (Homburg, DE)

Novel kidney injury markers (NGAL and KIM-1) and outcomes in patients with heart failure- Systematic review and meta-analysis

Speaker: Doctor A. Kumar (Little Rock, US)

Right ventricular dilatation as a manifestation of right ventricular dysfunction in patients with HFrEF: a new concept of evaluation

Speaker: Doctor J. Benes (Prague, CZ)

Combination treatment by epoxyeicosatrienoic acid analog and angiotensin-convertase enzyme inhibitor in congestive heart failure: a preclinical study on animal model

Speaker: Doctor P. Kala (Prague, CZ)

Long-term prognostic implications of in-hospital changes in N-terminal pro-B-type natriuretic peptide levels among hospitalized patients with atrial fibrillation with or without heart failure

Speaker: Mr A. Samaras (Thessaloniki, GR)

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 1

Speakers: Doctor J. Brito, Professor M. Boehm, Doctor A. Kumar, Doctor J. Benes, Doctor P. Kala...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources